Summary
A new cell line from the human umbilical vein has been established and maintained for more than 5 yr (180 generations; 900 population doublings). This strain, designated ECV304, is characterized by a cobblestone monolayer growth pattern, high proliferative potential without any specific growth factor requirement, and anchorage dependency with contact inhibition. Karyotype analysis of this cell line reveals it to be of human chromosomal constitution with a high trisomic karyotype (mode 80). Ultrastructurally, endothelium-specific Weibel-Palade bodies were identified. Although one of the endothelial cell markers, Factor VIII-related antigen (VIIIR:Ag) was negative in this cell line, immunocytochemical staining for the lectin Ulex europaeus I (UEA-I), and PHM5 (anti-human endothelium as well as glomerular epithelium monoclonal antibody) was positive, and angiotensin-converting enzyme (ACE) activity was also demonstrated. In addition, ECV304 displayed negativity for alkaline and acid phosphatase and for the epithelial marker keratin. All of these findings suggest that ECV304 cells originated from umbilical vein endothelial cells by spontaneous transformation. Ultrastructurally, no viruslike particles have been detected intracellularly. Nude mouse tumorigenicity and rabbit cornea tests were both positive. This is a report on a novel case of phenotypic alteration of normal venous endothelial cells of human origin in vitro, and generation of a transformant with indefinite life spans. This line may be useful in studies of some physiologically active factors available for medical use.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Chen, T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 104:255–262; 1977.
Chodak, G. W.; Haudenschild, C.; Gittes, R. F., et al. Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann. Surg. 192:762–771; 1980.
Clemmons, D. R.; Isley, W. L.; Brown, M. T. Dialyzable factor in human serum of platelet origin stimulates endothelial cell replication and growth. Proc. Natl. Acad. Sci. USA 80:1641–1645; 1983.
Cohen, S.; Johnson, A. R.; Hurd, E. Cytotoxicity of sera from patients with scleroderma. Arthritis Rheum. 26:170–178; 1983.
Connell, N. D.; Rheinwald, J. G. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34:245–253; 1983.
Eldor, A.; Fridman, R.; Vlodavsky, I., et al. Interferon enhances prostacyclin production by cultured vascular endothelial cells. J. Clin. Invest. 73:251–257; 1984.
Emeis, J. J.; Kooistra, T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J. Exp. Med. 163:1260–1266; 1986.
Faller, D. V.; Kourembanas, S.; Ginsberg, D., et al. Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation. J. Cell. Physiol. 134:47–56; 1988.
Folkman, J.; Cotran, R. Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Pathol. 16:207–248; 1976.
Gelehrter, T. D.; Sznycer-Laszuk, R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J. Clin. Invest. 77:165–169; 1986.
Gimbrone, M. A.; Cotran, R. S.; Leapman, S. B., et al. Tumor growth and neovascularization: an experimental model using the rabbit cornea. JNCI 52:413–427; 1974.
Gimbrone, M. A.; Gullino, P. M. Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues. JNCI 56:305–318; 1976.
Gimbrone, M. A.; Fareed, G. C. Transformation of cultured human vascular endothelium by SV40 DNA. Cell 9:685–693; 1976.
Gore, I.; Takada, M.; Austin, J. Ultrastructural basis of experimental thrombocytopenic purpura. Arch. Pathol. 90:197–205; 1970.
Gorman, S. D.; Hoffman, E.; Nichols, W. W., et al. Spontaneous transformation of a cloned cell line of normal diploid bovine vascular endothelial cells. In Vitro 20:339–345; 1984.
Grinspan, J. B.; Mueller, S. N.; Levine, E. M. Bovine endothelial cells transformed in vitro by benzo(a)pyrene. J. Cell Physiol. 114:328–338; 1983.
Hajjar, K. A.; Harpel, P. C.; Jaffe, E. A., et al. Binding of plasminogen to cultured human endothelial cells. J. Biol. Chem. 261:11656–11662; 1986.
Hancock, W. W.; Atkins, R. C. Monoclonal antibodies to human glomerular cells: a marker for glomerular epithelial cells. Nephron 33:83–90; 1983.
Hayes, L. W.; Goguen, C. A.; Ching, S. F., et al. Angiotensin-converting enzyme: accumulation in medium from cultured endothelial cells. Biochem. Biophys. Res. Commun. 82: 1147–1153; 1978.
Hobson, B.; Denekamp, J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br. J. Cancer 49:405–413; 1984.
Holthöfer, H.; Virtanen, I.; Kariniemi, A. L., et al. Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab. Invest. 47:60–66; 1982.
Jaffe, E. A.; Nachman, R. L.; Becker, C. G., et al. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:2745–2756; 1973.
Kakunaga, T. Neoplastic transformation of human diploid fibroblast cells by chemical carcinogens. Proc. Natl. Acad. Sci. USA 75:1334–1338; 1978.
Maciag, T.; Kadish, J.; Wilkins, L., et al. Organizational behavior of human umbilical vein endothelial cells. J. Cell Biol. 94:511–520; 1982.
Maruyama, Y. The human endothelial cell tissue culture. Z. Zellforsch. Microsk. Anat. 60:69; 1963.
Meischke, H. R. C. In vitro transformation by bovine papilloma virus. J. Gen. Virol. 43:473–487; 1979.
Mukai, K.; Rosai, J.; Burgdorf, W. H. C. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am. J. Surg. Pathol. 4:273–276; 1980.
Nichols, W. W.; Buynak, E. B.; Bradt, C., et al. Cytogenetic evaluation of human endothelial cell cultures. J. Cell Physiol. 132:453–462; 1987.
Olander, J. V.; Bremer, M. E.; Marasa, J. C., et al. Fibrinenhanced endothelial cell organization. J. Cell. Physiol. 125:1–9; 1985.
Rabinovitch, M.; Andreucci, D. A histochemical study of “acid” and “alkaline” phosphatase distribution in normal human bone marrow smears. Blood 4:580–594; 1949.
Sprengers, E. D.; Verheijen, J. H.; Van Hinsbergh, V. W. M., et al. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Biochem. Biophys. Acta 801:163–170; 1984.
Thornton, S. C.; Mueller, S. N.; Levine, E. M. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 222:623–625; 1983.
Van Hinsbergh, V. W. M.; Binnema, D.; Scheffer, M. A., et al. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis 7:389–400; 1987.
Weibel, E. R.; Palade, G. E. New cytoplasmic components in arterial endothelia. J. Cell Biol. 23:101–112; 1964.
Yamashita, Y.; Kobayashi, M.; Hasegawa, S., et al. Establishment of serum-free culture of human vascular endothelial cells. Tissue Culture Research Communication 7:139(abstract); 1988 (in Japanese).
Yanagisawa, M.; Kurihara, H.; Kimura, S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415; 1988.
Yuspa, S. H.; Hawley-Nelson, P.; Koehler, B., et al. A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res. 40:4694–4703; 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahashi, K., Sawasaki, Y., Hata, JI. et al. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 26, 265–274 (1990). https://doi.org/10.1007/BF02624456
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02624456